Infants of mothers treated in the first trimester with TMP-SMX appeared to have a higher risk for any malformation than those ...

A study of more than 70,000 US pregnancies suggests a commonly used antibiotic for urinary tract infections (UTIs) may be ...

Learn how Canada's GRDI AMR initiative tackles antimicrobial resistance across human, animal, and environmental health, with ...

Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections. The drug – a combination of beta-lactam antibiotic aztreonam with beta ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infections PIVYA expected to be available in the U.S. in the 4th ...

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...

The FDA has given the green light to Exblifep, based on long-established beta-lactam antibiotic cefepime and a new extended-spectrum beta-lactamase inhibitor (BLI) called enmetazobactam, for the ...

Antibiotic and other antimicrobial resistance could hamstring important medications. One Canadian initiative brings together researchers from across sectors to tackle the problem.

According to the Centers for Disease Control and Prevent: "Antibiotic resistance is one of the most urgent threats to the public's health." Here's why.

Recently, a research team successfully developed a series of CoNi-metal-organic framework (MOF) nanozymes with laccase-like activity using a gas-liquid interface dielectric barrier discharge (DBD) low ...